Concerns Over Valeant Spread to Other Drug Makers

As questions mount about the viability of Valeant Pharmaceuticals International’s business model, concerns are also spreading to other drug makers seen as following a similar playbook.

from WSJ.com: US Business http://ift.tt/1lDt9Ac
via IFTTT